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http://dx.doi.org/10.1016/j.fjs.2013.Summary Acquired hemophilia A (AHA) is a rare condition that predisposes affected patients
to a bleeding tendency, even after a trivial physical insult. We present our experience with a
45-year-old male patient who was referred to our institute because of persistent bleeding from
a left forearm surgical wound after fasciotomy. He was diagnosed as having AHA. Surgical
treatment in combination with recombinant activated factor VII (rFVIIa) led to a satisfactory
result. Clinical awareness and multidisciplinary professional connections are necessary in
the treatment of AHA. Acquired hemophilia should be considered in the differential diagnosis
of patients with uncontrolled bleeding episodes.
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Acquired hemophilia A (AHA) is a condition in which in-
hibitor autoantibodies are produced against coagulation
factor VIII.1 It is a rare condition, but the associated
morbidity and mortality rates are significant.2 Further-
more, although autoantibodies for other coagulation
factors may also develop, inhibitors of factor VIII are theciation. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 The left forearm on the third day after admission to
136 C.-W. Chang et al.most common.2 The incidence of AHA is estimated be-
tween 1.34 and 1.48 cases per million individuals each
year, and most (>85%) individuals with AHA are older
than 60 years.2 Some predisposing factors that have been
reported for AHA are postpartum status, underlying
autoimmune disease, and hematologic or solid cancer.3
Approximately one-half of AHA patients have no obvious
predisposing factors.4 The most common predisposing
conditions for AHA that have been reported are inter-
estingly autoimmune disease and malignancy, which have
prevalence rates of approximately 10% and 12%, respec-
tively.5 In this report we present a relatively young pa-
tient who had only a mild physical insult and a dramatic
consequence.our hospital. There were no obvious bleeders, but diffuse
wound oozing is present.2. Case report
A 45-year-old male patient had a medical history of un-
derlying gouty arthritis and cervical spine stenosis that
were surgically treated 5 years previously. He had a 2-
month history of repeated episodes of ecchymosis around
both forearms after minor contusions; however, these
symptomatic episodes usually subsided spontaneously.
Nothing of significance was noted after the evaluation of his
clinical history, except that he had taken an unknown
herbal medication for approximately 3 months prior to
hospitalization. His current problem followed an insult to
his left forearm, which was hit when playing with his son.
Progressive swelling, pain, and ecchymosis developed the
next day and did not subside. He was admitted to a local
hospital for treatment.
Progressive numbness, increasing swelling, and persistent
sharp pain occurred after hospitalization. In addition, weak
radial arterial pulsation was also noted (this was docu-
mented in the referring summary, which was maintained
among the medical records of our institute). Because of
suspected compartment syndrome, he underwent emer-
gency fasciotomy on day 2 of hospitalization. His preopera-
tive international normalized ratio (INR) was 0.98, and his
activated partial thromboplastin time (APTT) was more than
120 seconds (because of the emergency situation, the result
of the prothrombin/APTT [PT/APTT] test had apparently
been reported after he had been sent to the operating
room). However, persistent postoperative bleeding was
encountered at the surgical site. Additional attempts to
achieve hemostasis produced no obvious benefit, and the
patient’s clinical condition deteriorated. On postoperative
day (POD) 1, he had hypovolemic shock, changes in con-
sciousness, and a hemoglobin level of 4.9 g/dL. Emergency
resuscitation such as transfusion and fluid challenge were
persistently maintained. On POD 2, the patient was trans-
ferred to our institute for further management.
At our emergency department (ED), his initial vital
signs, including his level of consciousness, were docu-
mented as follows: body temperature of 36C, pulse rate of
138 beats per minute, respiratory rate of 26 breaths per
minute, systolic/diastolic blood pressure of 110/81 mmHg,
and alert. As Fig. 1 shows, the left forearm has a large
wound with diffuse oozing. Computed tomography was
performed at our ED. Active arterial bleeding was noted at
the elbow area (Fig. 2). The on-duty plastic surgeon wasconsulted immediately. However, no definite bleeding site
could be identified for suture and ligation. Epinephrine
gauze, elastic bandages, and a tourniquet system were all
applied for hemostasis. The patient was immediately
admitted to the intensive care unit (ICU) for close obser-
vation and correction of coagulopathy.
During the ICU admission, repeated episodes of massive
bleeding were noted, requiring multiple blood transfusions.
In addition, bedside suture ligation was performed several
times to control bleeding. Because of persistent bleeding
with coagulopathy, we consulted a hematologist for further
evaluation. The hematologist recommended several sur-
veys to assess the coagulopathy, including surveys that
evaluated mixing APTT, factor VIII, markers for autoim-
mune conditions, and possible malignancy.
On account of a prolonged mixing APTT (60.8 seconds)
and a low factor VIII level (1.5%), the hematologist rec-
ommended a supplemental factor VIII prescription and
measurement of factor VIII inhibitor titers. However, even
after supplementation of factor VIII, diffuse oozing per-
sisted. The factor VIII inhibitor titer was later reported to
be 23.52 Bethesda units (BU). A diagnosis of AHA was
established because of the high titer of factor VIII inhibitor
and low concentration of factor VIII. On POD 8, recombi-
nant activated factor VII (rFVIIa; NovoSeven RT; Novo
Nordisk Inc., West, Princeton, NJ, USA) was prescribed
(using 1-mg vials) to activate the extrinsic hemostasis
pathway, and prednisolone and cyclophosphamide were
administered to suppress factor VIII inhibitors.
Recombinant activated factor VII was administered by
intravenous infusion with seven vials every 2 hours for three
doses and was then changed to three vials every 6 hours for 2
days. After completing the first treatment cycle, mild oozing
of the wound persisted. We then initiated another cycle of
rFVIIa treatment, which was completed on POD 16. The pa-
tient’s later hospital course was uneven (he had an episode of
recurrent bleeding), however, he was fully recovered on POD
31 and was discharged with oral immunosuppressant agents.
Fig. 3 summarizes the serial hematological data and his
coagulation profile during the hospital stay.
This patient was then followed-up at the outpatient de-
partments of the trauma surgery and hematology de-
partments. Three months after the hospital discharge, the
factorVIII levelhad recoveredupto48%(the reference isabove
50%) and the immunosuppressant therapy was discontinued.
Figure 2 Computed tomography angiography revealed multiple small bleeders in the muscular branch of the left radial artery.
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The most common manifestation of AHA is acute bleeding
without an obvious family or personal history of a bleeding
disorder.2 Thebleeding episodes areusually inducedbyminor,
easily ignored injuries or by certain invasive procedures. The
most common bleeding sites include the skin, subcutaneous
tissue, muscle, and occasionally the retroperitoneum.6
Hemarthrosis, which is commonly noted in congenital hemo-
philia, interestingly is rarely observed in its acquired coun-
terpart. Well-organized, large series of data are lacking
because of the rarity of this disease. The results of the Euro-
pean Acquired Hemophilia (EACH2) Registry were recently
releasedwithmore than 500 enrolledpatients.5 This relatively
large series included patients from more than 100 treatment
centers in 13 European countries. It provided valuable de-
mographic data and some clinical information; however, het-
erogeneity of the included case studies could not be avoided
because of the rarity of this condition. According to the EACH2
study, the 5-year survival rate in patients who underwent in-
hibitor clean-up was 54%, and a poorer result was noted in
patients without inhibitor clean-up.5The compartment syndrome of the extremities is a surgical
emergency and emergency fasciotomy for pressure release
and limb preservation is always the first priority in treatment.
A combination of AHA and upper extremity compartment
syndrome has been reported, although very rarely.7 Both
surgical intervention and the cutting-edge biopharmaceutical
agent recombinant activated coagulation factor VII8 have
been reported with some limited experience.9 The patient in
our report could be a case of successful treatment, ifwe could
confirm the diagnosis of compartment syndrome. Because the
patient was transferred from another hospital to our care, we
did not have his complete primary clinical documentation or
preoperative image. In this report, we therefore cannot insist
that a relationship exists between compartment syndrome
and AHA.
According to the EACH2 study, the initiation of a he-
mostatic agent occurred within 1 day in 38.2% of patients,
although no significant prognostic difference was noted.5 In
the patient we have described, we initiated rFVIIa on POD
8. Further improvement in the diagnostic process is ex-
pected for similar cases. For the orthopedic or trauma
surgeon, knowing resuscitation skills is required. The
Figure 3 Hematological data during the hospital course. The arrows indicate the start of each cycle of recombinant factor VIIa
treatment (4 cycles in total). APTTZ activated partial thromboplastin time; HbZ hemoglobin; OPZ operation; PLTZ platelets;
PT Z prothrombin time.
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of diathesis. For patients with known acquired hemophilia,
prophylactic intervention is indicated. However, only a few
reports have provided clinical descriptions of the periop-
erative management of these patients.10e12 Moreover, the
current literature does not provide a consensus for pro-
phylactic intervention, with regard to the administered
agent or the strategy. Regular perioperative laboratory
check-ups with hematologist consultation and proper
medication (for example, rFVIIIa) will be essential in the
management of acquired hemophilia in patients for whom
surgery is inevitable.
Consent
The patient gave written, informed consent for the publi-
cation of this case report and any accompanying images. A
copy of the written consent is available for review from the
Editor-in-Chief of this journal.References
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